![Dose response curves of A549 and A549/PEM-1.6,-6.4 and-16 cells to PEM.... | Download Scientific Diagram Dose response curves of A549 and A549/PEM-1.6,-6.4 and-16 cells to PEM.... | Download Scientific Diagram](https://www.researchgate.net/publication/259354816/figure/fig1/AS:616353421619208@1523961515578/Dose-response-curves-of-A549-and-A549-PEM-16-64-and-16-cells-to-PEM-PEM-pemetrexed.png)
Dose response curves of A549 and A549/PEM-1.6,-6.4 and-16 cells to PEM.... | Download Scientific Diagram
![Oral pemetrexed facilitates low-dose metronomic therapy and enhances antitumor efficacy in lung cancer - ScienceDirect Oral pemetrexed facilitates low-dose metronomic therapy and enhances antitumor efficacy in lung cancer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S016836591830364X-fx1.jpg)
Oral pemetrexed facilitates low-dose metronomic therapy and enhances antitumor efficacy in lung cancer - ScienceDirect
![Phase 2 Study of Pemetrexed Plus Carboplatin, or Pemetrexed Plus Cisplatin with Concurrent Radiation Therapy Followed by Pemetrexed Consolidation in Patients with Favorable-Prognosis Inoperable Stage IIIA/B Non–Small-Cell Lung Cancer - Journal of Phase 2 Study of Pemetrexed Plus Carboplatin, or Pemetrexed Plus Cisplatin with Concurrent Radiation Therapy Followed by Pemetrexed Consolidation in Patients with Favorable-Prognosis Inoperable Stage IIIA/B Non–Small-Cell Lung Cancer - Journal of](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2040329461/2053819815/gr1.jpg)
Phase 2 Study of Pemetrexed Plus Carboplatin, or Pemetrexed Plus Cisplatin with Concurrent Radiation Therapy Followed by Pemetrexed Consolidation in Patients with Favorable-Prognosis Inoperable Stage IIIA/B Non–Small-Cell Lung Cancer - Journal of
![Pemetrexed and cisplatin as first-line chemotherapy for advanced non-small-cell lung cancer (NSCLC) with asymptomatic inoperable brain metastases: a multicenter phase II trial (GFPC 07-01) - Annals of Oncology Pemetrexed and cisplatin as first-line chemotherapy for advanced non-small-cell lung cancer (NSCLC) with asymptomatic inoperable brain metastases: a multicenter phase II trial (GFPC 07-01) - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/49792743-57fe-49fc-962f-f98b5e025821/gr1_lrg.jpg)
Pemetrexed and cisplatin as first-line chemotherapy for advanced non-small-cell lung cancer (NSCLC) with asymptomatic inoperable brain metastases: a multicenter phase II trial (GFPC 07-01) - Annals of Oncology
![Prediction of Renal Transporter Mediated Drug-Drug Interactions for Pemetrexed Using Physiologically Based Pharmacokinetic Modeling | Drug Metabolism & Disposition Prediction of Renal Transporter Mediated Drug-Drug Interactions for Pemetrexed Using Physiologically Based Pharmacokinetic Modeling | Drug Metabolism & Disposition](https://dmd.aspetjournals.org/content/dmd/43/3/325/F4.large.jpg)
Prediction of Renal Transporter Mediated Drug-Drug Interactions for Pemetrexed Using Physiologically Based Pharmacokinetic Modeling | Drug Metabolism & Disposition
![Fresenius Kabi Introduces New Generic for the Treatment of Non-Squamous Non-Small Cell Lung Cancer | Business Wire Fresenius Kabi Introduces New Generic for the Treatment of Non-Squamous Non-Small Cell Lung Cancer | Business Wire](https://mms.businesswire.com/media/20220531005701/en/1471357/5/PEMEtrexed.jpg)
Fresenius Kabi Introduces New Generic for the Treatment of Non-Squamous Non-Small Cell Lung Cancer | Business Wire
البورد العراقي للصيدلة السريرية - Alimta® (pemetrexed) 💎 Note: Start vitamin supplements 1 week before initial pemetrexed dose: Folic acid 400 to 1,000 mcg orally once daily (begin 7 days prior to
![Dose escalation study of carboplatin–pemetrexed followed by maintenance pemetrexed for elderly patients with advanced nonsquamous nonsmall-cell lung cancer - Annals of Oncology Dose escalation study of carboplatin–pemetrexed followed by maintenance pemetrexed for elderly patients with advanced nonsquamous nonsmall-cell lung cancer - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/6b0ce79c-8a60-4aa5-9791-bd42c1247792/gr1.jpg)
Dose escalation study of carboplatin–pemetrexed followed by maintenance pemetrexed for elderly patients with advanced nonsquamous nonsmall-cell lung cancer - Annals of Oncology
![A phase IB dose-escalation study of the safety and pharmacokinetics of pictilisib in combination with either paclitaxel and carboplatin (with or without bevacizumab) or pemetrexed and cisplatin (with or without bevacizumab) in A phase IB dose-escalation study of the safety and pharmacokinetics of pictilisib in combination with either paclitaxel and carboplatin (with or without bevacizumab) or pemetrexed and cisplatin (with or without bevacizumab) in](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/bad6523d-6b9f-43b0-8662-ea2c7991f945/gr1_lrg.jpg)
A phase IB dose-escalation study of the safety and pharmacokinetics of pictilisib in combination with either paclitaxel and carboplatin (with or without bevacizumab) or pemetrexed and cisplatin (with or without bevacizumab) in
![Impact of pemetrexed chemotherapy on the gut microbiota and intestinal inflammation of patient-lung-derived tumor xenograft (PDX) mouse models | Scientific Reports Impact of pemetrexed chemotherapy on the gut microbiota and intestinal inflammation of patient-lung-derived tumor xenograft (PDX) mouse models | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-020-65792-6/MediaObjects/41598_2020_65792_Fig1_HTML.png)